Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hamblin

Showing results (61-70 of 264) with videos related to

Pageof 27
Sort By:
Leukemia Research|July 28, 2009
Just exactly how common is CLL?Terry J Hamblin
Comprehensive Therapy|December 1, 1991
Interleukin-2 for anti-cancer therapyT J Hamblin
Leukemia Research|August 23, 2005
The management of anemia in the myelodysplastic syndromeTerry J Hamblin
British Medical Journal|August 27, 2010
Reading for Pleasure: More worlds per poundT J Hamblin
British Medical Journal (Clinical Research Ed.)|August 30, 1986
Blood transfusions and cancer: anomalies explained?T J Hamblin
British Medical Journal (Clinical Research Ed.)|January 24, 1981
Plasma exchange to control sweats and pruritus in malignant diseaseT J Hamblin
British Medical Journal (Clinical Research Ed.)|August 14, 1982
Immune guided missilesT J Hamblin
British Medical Journal (Clinical Research Ed.)|October 23, 1982
Apheresis therapy: spin-drying the bloodT J Hamblin
Bristol Medico-Chirurgical Journal (1963)|October 1, 1970
The problems of anticoagulant control. 1. Drug interactionsT J Hamblin
BMJ (Clinical Research Ed.)|February 12, 2024
WhatsApp is a sticking plaster for poor systems of care coordinationDavid J Hamblin-Brown
Pageof 27

Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
Leukemia Research|July 28, 2009
Just exactly how common is CLL?Terry J Hamblin
Comprehensive Therapy|December 1, 1991
Interleukin-2 for anti-cancer therapyT J Hamblin
Leukemia Research|August 23, 2005
The management of anemia in the myelodysplastic syndromeTerry J Hamblin
British Medical Journal|August 27, 2010
Reading for Pleasure: More worlds per poundT J Hamblin
British Medical Journal (Clinical Research Ed.)|August 30, 1986
Blood transfusions and cancer: anomalies explained?T J Hamblin
British Medical Journal (Clinical Research Ed.)|January 24, 1981
Plasma exchange to control sweats and pruritus in malignant diseaseT J Hamblin
British Medical Journal (Clinical Research Ed.)|August 14, 1982
Immune guided missilesT J Hamblin
British Medical Journal (Clinical Research Ed.)|October 23, 1982
Apheresis therapy: spin-drying the bloodT J Hamblin
Bristol Medico-Chirurgical Journal (1963)|October 1, 1970
The problems of anticoagulant control. 1. Drug interactionsT J Hamblin
BMJ (Clinical Research Ed.)|February 12, 2024
WhatsApp is a sticking plaster for poor systems of care coordinationDavid J Hamblin-Brown
Pageof 27